Evidence map›Paper›PMID 36277331›Full record

ReviewNeurology research international2022

Managing Chronic Neuropathic Pain: Recent Advances and New Challenges.

Namrata Hange, Sujan Poudel, Saleha Ozair, Trissa Paul, Meghna Nambakkam, Rakchhya Shrestha, Farrah Greye, Sangam Shah, Yagya Raj Adhikari, Sangharsha Thapa and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Neurology research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Resonance massage tool effects in non-migraine headache management.Journal of oral & facial pain and headache · 2025
    Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Observational
  18. Article
  19. Discovery of New 3-(Benzo[Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Namrata HangeNational University of Singapore, Singapore.
Sujan PoudelNational Medical College, Tribhuvan University, Birgunj, Nepal.ORCID https://orcid.org/0000-0002-5450-2095
Saleha OzairDepartment of Research & Academic Affairs, Larkin Community Hospital, South Miami, FL, USA.
Trissa PaulLarkin Community Hospital, Miami, Florida, USA.
Meghna NambakkamDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
Rakchhya ShresthaDepartment of Internal Medicine, Ascension St. Agnes Hospital, Baltimore, MD, USA.
Farrah GreyeDepartment of Research & Academic Affairs, Larkin Community Hospital, South Miami, FL, USA.
Sangam ShahTribhuvan University, Institute of Medicine, Maharajgunj, Kirtipur 44600, Nepal.ORCID https://orcid.org/0000-0002-8203-3329
Yagya Raj AdhikariTribhuvan University, Institute of Medicine, Maharajgunj, Kirtipur 44600, Nepal.
Sangharsha ThapaUniversity of Minnesota, Minneapolis, MN, USA.
Pooja PatelDepartment of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.
Larkin Community Hospital · USTribhuvan University · NPNational University of Singapore · SGSaint Agnes Hospital · USUniversity of Kansas Medical Center · USUniversity of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Neuropathic pain affects 7-10% of the population, with most of the patients receiving inadequate and incomplete treatment. Owing to the high financial burden and the poor quality of life of the patients and their caretakers, there is a dire need to address the challenges in diagnosing and treating chronic neuropathic pain. Methods: This literature review was conducted to review novel treatments and related challenges through a systematic search from sources such as PubMed, Google Scholar with the combination of MESH words such as neuropathic pain, management of neuropathic pain. Articles from non-English literature, reports without human subjects, animal studies, and abstracts/posters were excluded. However, human studies and studies published in English were included. Result: This review article discusses novel treatment modalities while acknowledging the challenges medical workers face while encountering neuropathic pain. Despite the recent advances in diagnosis and treatment modalities, several challenges still exist. Hence, there is still a need to explore the various treatment modalities, emphasizing the cause and underlying pathophysiology of neuropathic pain. Conclusion: We recommend integrated multimodal treatment with the current treatment facility, including various medical disciplines. However, a personalized approach would work the best depending on the 'patient's medical history. Therefore, this article recommends an integrated, cause-specific, cost-effective approach to address this problem of chronic neuropathic pain.

Identifiers

PMID36277331
PMCPMC9581623
OpenAlexW4304759041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.